Clinical Trials Results - National Cancer Institute

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

In English \| En español
Search

NCI Home

Cancer Topics


	Clinical Trials Search Results

Page Options

E-Mail This Search

Clinical Trial Questions?

Get Help:

1-800-4-CANCER or

LiveHelp online chat

	Quick Links


	Help Using the NCI Clinical Trials Search Form Educational Materials About Clinical Trials About NCI's Cancer Clinical Trials Registry Dictionary of Cancer Terms NCI Drug Dictionary

View Content for:

Patients
Health Professionals

Display:

Title
Description with: Locations Eligibility
Full Trial Description
Custom

Results 1-25 of 35 for your search:

Cancer Type:  Prostate cancer
Treatment/Intervention:  complementary or alternative medicine procedure
Trial Status:  Active

Hide Search Criteria

Show Search Criteria

Help with Results

Select All on Page Sort by: Show Results per Page

Phase II/III Randomized Study of Adjuvant Soy Protein Isolate in Preventing Recurrence in Patients Who Have Undergone Radical Prostatectomy for Stage II Prostate Cancer

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 40 to 75
Sponsor: NCI
Protocol IDs: UIC-2006-0706, 2006-0706, NCT00765479

Role of Soy Supplementation in Prostate Cancer Development

Phase: Phase III
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CLIN-006-05S, NCT00255125

Phase III Randomized Study of Pomegranate Extract in Patients With Rising Prostate-Specific Antigen Levels After Surgery or Radiotherapy for Localized Prostate Cancer

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: ROLL-GUP-0205-1, UCLA-0507059-01, NCT00336934

Phase III Randomized Study of Soy Protein/Isoflavones and Venlafaxine on Vasomotor Symptoms in Patients With Prostate Cancer Undergoing Hormonal Manipulation

Phase: Phase III
Type: Supportive care
Status: Active
Age: 21 and over
Sponsor: NCI
Protocol IDs: CCCWFU-97405, CCCWFU 97405, CCCWFU-BG05-529, NCT00354432

Phase III Randomized Study of Pelvic Floor Muscle Training and Biofeedback in Men With Prostate Cancer Who Have Undergone Radical Prostatectomy or Men With Benign Prostatic Hypertrophy Who Have Undergone Transurethral Resection

Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: ABROIN-MAPS, MAPS, ISRCTN87696430, NCT00632138

Exercise in Men Receiving Radiation Therapy for Prostate Cancer.

Phase: Phase III
Type: Supportive care
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: NCIC 013232, OTT 02-04, CERHO 2002263-01H, NCT00253916

Biomarker Study of Neoadjuvant Vitamin E in Patients With Locally Treatable Prostate Cancer Prior to Prostatectomy or Brachytherapy

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: INST 0808, NCT00809458

Reiki/Energy Healing in Prostate Cancer

Phase: Phase II, Phase I
Type: Supportive care, Treatment
Status: Active
Age: Not specified
Sponsor: NCCAM
Protocol IDs: R21 AT001120, NCT00065208

Acupuncture Treatment for Hot Flashes Study

Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NYM # 325, NCT00421902

10.

Phase II Randomized Pilot Study of Calcitriol and Dexamethasone Before Radical Prostatectomy in Patients With Localized Adenocarcinoma of the Prostate

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-RP-0212, NCT00084864

11.

Phase II Randomized Study of Neoadjuvant Lycopene Supplementation in Patients Undergoing Radical Prostatectomy for Prostate Cancer

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-04-3-01, MDA04-3-01, NCT00450749, MSKCC-06118, MDA-CC-2006-0388

12.

Phase II Study of Cholecalciferol and Soy Supplementation in Patients With Biochemically Recurrent Prostate Cancer Following Failed Definitive Local Therapy

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 18
Sponsor: NCI
Protocol IDs: CCCWFU-85106, CCCWFU-IRB00000371, CCCWFU 85106, NCT00499408

13.

Phase II Randomized Study of Different Doses of Cholecalciferol (Vitamin D) in Patients With Prostate Cancer

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-I-95406, I 95406, NCT00524680

14.

Herbal Therapy for Treatment of Recurrent Prostate Cancer

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4P-07-3, NCT00669656

15.

Study of Polyphenon E in Men With High-Grade Prostatic Intraepithelial Neoplasia

Phase: Phase II
Type: Prevention
Status: Active
Age: 30 to 80
Sponsor: NCI, Other
Protocol IDs: MCC 15008, USF#105730, RO1 CA12060-01A1, NCT00596011

16.

Phase II Randomized Study of Selenomethionine and Finasteride Prior to Prostatectomy in Patients With Stage I or II Prostate Cancer

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-I-104607, I 104607, NCT00736645

17.

Phase II Randomized Study of Selenomethionine Supplementation in Patients Undergoing Prostatectomy or Brachytherapy for Stage I or II Prostate Cancer

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: RPCI-I-104307, I 104307, NCT00736164

18.

Open-Label Extension Study of the Effects of Pomegranate Extract on Rising PSA After Primary Therapy for Prostate Cancer

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GUP-0205-1X, NCT00731848

19.

Extension to Study of Effects of Pomegranate Extract on Rising PSA Levels After Primary Therapy for Prostate Cancer

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: GUP-0205-1XX, NCT00732043

20.

Vitamin D Effects on Prostate Pathology

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 to 85
Sponsor: Other
Protocol IDs: M2140, NCT00741364

21.

Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active Surveillance

Phase: Phase II
Type: Biomarker/Laboratory analysis, Diagnostic, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-0580-B, NCT00744549

22.

Phase II Randomized Study of Selenium in Patients With Adenocarcinoma of the Prostate

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Under 85
Sponsor: NCI
Protocol IDs: UARIZ-97-0395, UARIZ-HSC-97-57, Watchful Waiting, NCT00752739

23.

Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate Cancer

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 08-0604-CE, NCT00844792

24.

Phase II Study of Neoadjuvant Oral Microencapsulated Diindolylmethane in Patients With Stage I or II Adenocarcinoma of the Prostate Undergoing Radical Prostatectomy

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: NCI
Protocol IDs: WSU-2007-128, 2007-128, NCT00888654

25.

Phase I Study of Defined Green Tea Catechin Extract in Patients With Prostate Cancer Scheduled to Undergo Prostatectomy

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: UARIZ-UAZ05-6-01, UAZ05-6-01, HSC# 06-0695-04, UARIZ-HSC-06-0695-04, NCT00459407

Select All on Page

Help with Results

A Service of the National Cancer Institute